View in EDS

In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.

Saved in:

Bibliographic Details
Title:	In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.
Authors:	Debnath T; University of Wisconsin-Madison Madison, Wisconsin United States., Jin WJ; University of Wisconsin-Madison Madison, Wisconsin United States., Patel RB; UPMC Hillman Cancer Center Pittsburgh, Pennsylvania United States., Carlson PM; Emory University Atlanta, Georgia United States., Rahman MM; University of Wisconsin-Madison Madison United States., Berg TJ; University of Wisconsin-Madison Madison, Wisconsin United States., Kerr CP; University of Wisconsin-Madison Madison, Wisconsin United States., Schwartz RW; University of Wisconsin-Madison Madison, WI United States., Wang Y; University of Wisconsin-Madison Madison, Wisconsin United States., Hyun M; University of Wisconsin-Madison Madison, Wisconsin United States., Ong IM; University of Wisconsin-Madison Madison, WI United States., Weichert JP; University of Wisconsin-Madison Madison, WI United States., Hernandez R; University of Wisconsin-Madison Madison, WI United States., Sondel PM; University of Wisconsin-Madison Madison, WI United States., Morris ZS; University of Wisconsin-Madison Madison, Wisconsin United States.
Source:	Cancer immunology research [Cancer Immunol Res] 2026 Jul 08. Date of Electronic Publication: 2026 Jul 08.
Publication Type:	Journal Article
Journal Info:	Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2326-6074
DOI:	10.1158/2326-6066.CIR-25-1475